OAR 332-026-0010
Approved Legend Drugs For Maternal Use

An LDM may administer the following legend drugs as approved by the Board for maternal use:
(1) Anti-Hemorrhagics for use by intramuscular injection includes:
(a) Synthetic Oxytocin (Pitocin, Syntocin and generic);
(b) Methylergonovine (Methergine);
(c) Ergonovine (Ergotrate); or
(2) Anti-Hemorrhagics by intravenous infusion is limited to Synthetic Oxytocin (Pitocin, Syntocin, and generic).
(3) Anti-Hemorrhagics for oral administration is limited to:
(a) Methylergonovine (Methergine);
(b) Misoprostol (Cytotec).
(4) Anti-Hemorrhagics for rectal administration is limited to Misoprostol (Cytotec).
(5) Resuscitation is limited to medical oxygen and intravenous fluid replacement.
(6) Intravenous fluid replacement includes:
(a) Lactated Ringers Solution;
(b) 0.9% Saline Solution;
(c) D5LR (5% Dextrose in Lactated Ringers); or
(d) D5W (5% Dextrose in water).
(7) Anaphylactic treatment by subcutaneous injection is limited to Epinephrine.
(8) Local anesthetic includes:
(a) Lidocaine HCl (1% and 2%) (Xylocaine and generic);
(b) Topical anesthetic;
(c) Procaine HCl (Novocain, benzocaine, cetacane and generic); and
(d) Sterile water papules.
(9) Rhesus Sensitivity Prophylaxis is limited to Rho(d) Immune Globulin (RhoGAM, Gamulin Rh, Bay Rho-D and others).
(10) Tissue adhesive (Dermabond or generic).
(11) Intravenous antibiotics for Group B Streptococcal prophylaxis is limited to the following and is only to be used solely for the purpose of Group B Streptococcal prophylaxis:
(a) Penicillin;
(b) Ampicillin;
(c) Cefazolin; or
(d) Clindamycin.

Source: Rule 332-026-0010 — Approved Legend Drugs For Maternal Use, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=332-026-0010.

Last Updated

Jun. 8, 2021

Rule 332-026-0010’s source at or​.us